These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

837 related items for PubMed ID: 34996879

  • 1. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ, Chen CC, Liao HY, Lin YT, Wu YW, Liou JM, Wu MS, Kuo CH, Lin CH.
    Neurology; 2022 Feb 22; 98(8):e848-e858. PubMed ID: 34996879
    [Abstract] [Full Text] [Related]

  • 2. Parkinson's Disease Is Associated with Impaired Gut-Blood Barrier for Short-Chain Fatty Acids.
    Yang X, Ai P, He X, Mo C, Zhang Y, Xu S, Lai Y, Qian Y, Xiao Q.
    Mov Disord; 2022 Aug 22; 37(8):1634-1643. PubMed ID: 35607987
    [Abstract] [Full Text] [Related]

  • 3. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease.
    Aho VTE, Houser MC, Pereira PAB, Chang J, Rudi K, Paulin L, Hertzberg V, Auvinen P, Tansey MG, Scheperjans F.
    Mol Neurodegener; 2021 Feb 08; 16(1):6. PubMed ID: 33557896
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson's Disease (PD).
    Du J, Zhang P, Tan Y, Gao C, Liu J, Huang M, Li H, Shen X, Huang P, Chen S.
    Mov Disord; 2024 Aug 08; 39(8):1397-1402. PubMed ID: 38561921
    [Abstract] [Full Text] [Related]

  • 6. Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease.
    Chen SJ, Chen CC, Liao HY, Wu YW, Liou JM, Wu MS, Kuo CH, Lin CH.
    J Parkinsons Dis; 2022 Aug 08; 12(4):1219-1230. PubMed ID: 35342048
    [Abstract] [Full Text] [Related]

  • 7. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
    de la Cuesta-Zuluaga J, Mueller NT, Álvarez-Quintero R, Velásquez-Mejía EP, Sierra JA, Corrales-Agudelo V, Carmona JA, Abad JM, Escobar JS.
    Nutrients; 2018 Dec 27; 11(1):. PubMed ID: 30591685
    [Abstract] [Full Text] [Related]

  • 8. Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson's Disease - The RESISTA-PD Trial.
    Becker A, Schmartz GP, Gröger L, Grammes N, Galata V, Philippeit H, Weiland J, Ludwig N, Meese E, Tierling S, Walter J, Schwiertz A, Spiegel J, Wagenpfeil G, Faßbender K, Keller A, Unger MM.
    Genomics Proteomics Bioinformatics; 2022 Apr 27; 20(2):274-287. PubMed ID: 34839011
    [Abstract] [Full Text] [Related]

  • 9. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Bürmann J, Faßbender K, Schwiertz A, Schäfer KH.
    Parkinsonism Relat Disord; 2016 Nov 27; 32():66-72. PubMed ID: 27591074
    [Abstract] [Full Text] [Related]

  • 10. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
    Zhong C, Dai Z, Chai L, Wu L, Li J, Guo W, Zhang J, Zhang Q, Xue C, Lin H, Luo Q, Cai K.
    J Clin Lab Anal; 2021 Dec 27; 35(12):e24062. PubMed ID: 34689373
    [Abstract] [Full Text] [Related]

  • 11. Fecal Short-Chain Fatty Acids Are Not Predictive of Colonic Tumor Status and Cannot Be Predicted Based on Bacterial Community Structure.
    Sze MA, Topçuoğlu BD, Lesniak NA, Ruffin MT, Schloss PD.
    mBio; 2019 Jul 02; 10(4):. PubMed ID: 31266879
    [Abstract] [Full Text] [Related]

  • 12. Imbalance of Microbacterial Diversity Is Associated with Functional Prognosis of Stroke.
    Zhang X, Wang X, Zhao H, Cao R, Dang Y, Yu B.
    Neural Plast; 2023 Jul 02; 2023():6297653. PubMed ID: 37197229
    [Abstract] [Full Text] [Related]

  • 13. Sustained Dysbiosis and Decreased Fecal Short-Chain Fatty Acids after Traumatic Brain Injury and Impact on Neurologic Outcome.
    Opeyemi OM, Rogers MB, Firek BA, Janesko-Feldman K, Vagni V, Mullett SJ, Wendell SG, Nelson BP, New LA, Mariño E, Kochanek PM, Bayır H, Clark RSB, Morowitz MJ, Simon DW.
    J Neurotrauma; 2021 Sep 15; 38(18):2610-2621. PubMed ID: 33957773
    [Abstract] [Full Text] [Related]

  • 14. Plasma Short-Chain Fatty Acids in Patients With Parkinson's Disease.
    Shin C, Lim Y, Lim H, Ahn TB.
    Mov Disord; 2020 Jun 15; 35(6):1021-1027. PubMed ID: 32154946
    [Abstract] [Full Text] [Related]

  • 15. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics.
    Tan AH, Chong CW, Lim SY, Yap IKS, Teh CSJ, Loke MF, Song SL, Tan JY, Ang BH, Tan YQ, Kho MT, Bowman J, Mahadeva S, Yong HS, Lang AE.
    Ann Neurol; 2021 Mar 15; 89(3):546-559. PubMed ID: 33274480
    [Abstract] [Full Text] [Related]

  • 16. Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors.
    Nomura M, Nagatomo R, Doi K, Shimizu J, Baba K, Saito T, Matsumoto S, Inoue K, Muto M.
    JAMA Netw Open; 2020 Apr 01; 3(4):e202895. PubMed ID: 32297948
    [Abstract] [Full Text] [Related]

  • 17. Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy.
    Chai L, Luo Q, Cai K, Wang K, Xu B.
    BMC Nephrol; 2021 Jun 03; 22(1):209. PubMed ID: 34082732
    [Abstract] [Full Text] [Related]

  • 18. Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson's disease.
    Huang P, Zhang P, Du J, Gao C, Liu J, Tan Y, Chen S.
    NPJ Parkinsons Dis; 2023 Jul 17; 9(1):115. PubMed ID: 37460569
    [Abstract] [Full Text] [Related]

  • 19. Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity.
    Tews HC, Elger T, Gunawan S, Fererberger T, Sommersberger S, Loibl J, Huss M, Liebisch G, Müller M, Kandulski A, Buechler C.
    Lipids Health Dis; 2023 Oct 03; 22(1):164. PubMed ID: 37789460
    [Abstract] [Full Text] [Related]

  • 20. Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.
    Chu JR, Kang SY, Kim SE, Lee SJ, Lee YC, Sung MK.
    World J Gastroenterol; 2019 Oct 28; 25(40):6129-6144. PubMed ID: 31686768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.